VITR — Vitrolife AB Balance Sheet
0.000.00%
- SEK20.31bn
- SEK21.21bn
- SEK3.61bn
Annual balance sheet for Vitrolife AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 974 | 630 | 578 | 861 | 1,135 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 226 | 431 | 542 | 582 | 734 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,414 | 1,407 | 1,572 | 1,914 | 2,357 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 142 | 333 | 318 | 349 | 428 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,305 | 19,429 | 20,551 | 16,329 | 17,446 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 177 | 954 | 621 | 557 | 705 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 293 | 4,107 | 3,815 | 3,607 | 3,807 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2,013 | 15,322 | 16,736 | 12,722 | 13,639 |
Total Liabilities & Shareholders' Equity | 2,305 | 19,429 | 20,551 | 16,329 | 17,446 |
Total Common Shares Outstanding |